Ph.D. in molecular medicine at Vita-Salute San Raffaele University of Milan, Michela contributed to the advancement of gene therapy for hemophilia and to the understanding of the biology of liver stem cells at San Raffaele Telethon Institute for Gene Therapy. She developed new lentiviral vectors tailored for in vivo use to achieve efficient and safe gene transfer in non-human primates. Recently, she broadened her interests in in vivo lentiviral vector-mediated gene therapy by showing effective and stable gene transfer into hematopoietic stem and progenitor cells in newborn mice. Currently, she is a Project Leader at the San Raffaele Telethon Institute for Gene Therapy, where she will continue developing new strategies for improved in vivo genetic engineering.